Arthritis Drugs Linked to Serious Fungal Diseases

(openPR) - The Law Offices of James Sokolove (LOJS), dedicated to providing equal access to the civil justice system, sees the stricter medication guides now required by the Food & Drug Administration (FDA) on certain arthritis drugs as consumer critical. The FDA took action following the more than 200 reports that associated higher incidences of fungal infections, and even deaths, with the use of four tumor necrosis factor alpha blockers (TNF-alpha blockers) arthritis drugs.

“For the over 1 million Americans suffering from rheumatoid arthritis and facing chronic and debilitating pain, drugs, such as these, can help create normalcy in their daily lives,” says Attorney Jim Sokolove, founder of the LOJS. “While the FDA has responded here, consumers must remain highly vigilant themselves, so they can weigh the relief versus the risks imposed in using any drug.” More...